Ardelyx (ARDX) Inventory Average (2022 - 2026)
Ardelyx (ARDX) reported Inventory Average of $20.2 million for Q1 2026, down 9.94% on a YoY basis from $22.5 million in Q1 2025, and down 5.66% quarter-over-quarter from $21.5 million in Q4 2025.
Ardelyx (ARDX) Inventory Average (2022 - 2026) Analysis & Trends
Ardelyx has reported Inventory Average for 5 years, with the latest figure at $20.2 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average fell 9.94% year-over-year to $20.2 million; the trailing twelve-month figure through Mar 2026 stood at $20.2 million (down 9.94% YoY), and the FY2025 full-year result was $19.5 million, up 15.73% from the prior year.
- Inventory Average for Q1 2026 stood at $20.2 million, down from $21.5 million in the prior quarter.
- The five-year high for Inventory Average was $23.7 million in Q3 2025, with the low at $2.3 million in Q4 2022.
- Historically, Inventory Average has averaged $12.5 million across 5 years, with a median of $11.5 million in 2024.
- Annual changes were most pronounced in 2023 — Inventory Average jumped 362.75% — and 2026, when it decreased 9.94%.
- Ardelyx's Inventory Average stood at $2.3 million in 2022, then soared by 362.75% to $10.5 million in 2023, then surged by 55.21% to $16.3 million in 2024, then surged by 31.81% to $21.5 million in 2025, then declined by 5.66% to $20.2 million in 2026.
- The last three Inventory Average figures came in at $20.2 million (Q1 2026), $21.5 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 20.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.24 Mn |
| Dec 31, 2025 | 21.45 Mn |
| Sep 30, 2025 | 23.72 Mn |
| Jun 30, 2025 | 23.03 Mn |
| Mar 31, 2025 | 22.47 Mn |
| Dec 31, 2024 | 16.28 Mn |
| Sep 30, 2024 | 12.57 Mn |
| Jun 30, 2024 | 11.78 Mn |
| Mar 31, 2024 | 11.13 Mn |
| Dec 31, 2023 | 10.49 Mn |
| Sep 30, 2023 | 8.07 Mn |
| Jun 30, 2023 | 6.22 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 2.89 Mn |
| Jun 30, 2022 | 4.01 Mn |